Mechanisms of hypertension in autoimmune rheumatic diseases

Erin B. Taylor, Victoria L. Wolf, Elena Dent, Michael J. Ryan

Research output: Contribution to journalReview articlepeer-review


Patients with autoimmune rheumatic diseases including rheumatoid arthritis and systemic lupus erythematosus have an increased prevalence of hypertension. There is now a large body of evidence showing that the immune system is a key mediator in both human primary hypertension and experimental models. Many of the proposed immunological mechanisms leading to primary hypertension are paralleled in autoimmune rheumatic disorders. Therefore, examining the link between autoimmunity and hypertension can be informative for understanding primary hypertension. This review examines the prevalent hypertension, the immune mediators that contribute to the prevalent hypertension and their impact on renal function and how the risk of hypertension is potentially influenced by common hormonal changes that are associated with autoimmune rheumatic diseases. Linked Articles: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit

Original languageEnglish (US)
Pages (from-to)1897-1913
Number of pages17
JournalBritish Journal of Pharmacology
Issue number12
StatePublished - Jun 2019
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Mechanisms of hypertension in autoimmune rheumatic diseases'. Together they form a unique fingerprint.

Cite this